APA (7th ed.) Citation

R, O., N, M., & K, T. (2025). Pediatric-Specific Drug Loss Issue in Japan: Comparison of Pediatric Development Status Between Japan and the United States. Therapeutic innovation & regulatory science, 59(1), 142. https://doi.org/10.1007/s43441-024-00714-6

Chicago Style (17th ed.) Citation

R, Osako, Matsumaru N, and Tsukamoto K. "Pediatric-Specific Drug Loss Issue in Japan: Comparison of Pediatric Development Status Between Japan and the United States." Therapeutic Innovation & Regulatory Science 59, no. 1 (2025): 142. https://doi.org/10.1007/s43441-024-00714-6.

MLA (9th ed.) Citation

R, Osako, et al. "Pediatric-Specific Drug Loss Issue in Japan: Comparison of Pediatric Development Status Between Japan and the United States." Therapeutic Innovation & Regulatory Science, vol. 59, no. 1, 2025, p. 142, https://doi.org/10.1007/s43441-024-00714-6.